Blockade of tumor-derived Igα inhibited the growth, viability, and access of S phase of cancer cells including HeLa and CNE1 by anti-human Igα antibody, suggesting that tumor-derived Igα promoted cancer cell growth [74]. The gene discussed is CD79A; the disease is cancer.